|
[1]
|
Moskowitz, C. (2008) Why We Fear Snakes? Live Science, 1.
http://www.livescience.com/2348-fear-snakes.html
|
|
[2]
|
Vyas, V.K., Brahmbhatt, K., Bhatt, H. and Parmar, U. (2013) Therapeutic Potential of Snake Venom in Cancer Therapy: Current Perspectives. Asian Pacific Journal of Tropical Biomedicine, 3, 156-162.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3627178/#!po=71.8750
|
|
[3]
|
Perkel, J.M. (2008) Snake Venomics Uncoils Venom Composition, Evolution. Journal of Proteome, 7, 3067.
http://pubs.acs.org/doi/abs/10.1021/pr800479x
http://dx.doi.org/10.1021/pr800479x
|
|
[4]
|
Liu, Y., Wang, X.J., Wu, Z., Chen, P., Nie, D.S., Yi, J.M., Yi, J.Z. and Liu, Z.G. (2012) Electrophysiological and Proteomic Studies of Protobothrops mangshensis Venom Revealed Its High Bioactivities and Toxicities. Journal of Integrated Omics, 2, 132-139.
http://www.jiomics.com/index.php/jio/article/view/114/106
|
|
[5]
|
Paulchamy, C. (2009) Pharmacological Perspectives of Snake Venoms from Viperidae Family. The Internet Journal of Pharmacology, 8, 1.
http://ispub.com/IJPHARM/8/2/6664
|
|
[6]
|
Fox News (2012) Snake Venom Could Be Used to Treat Cancer, Diabetes.
http://www.foxnews.com/health/2012/09/20/snake-venom-could-be-used-to-develop-drugs-for-cancer-diabetes
|
|
[7]
|
Cavaliere, V. (2012) Snake Venom Could Hold Cure for Cancer, Diabetes: Study. New York Daily News, 1.
http://www.nydailynews.com/life-style/health/snake-venom-hold-cures-cancer-diabetes-study-article-1.1162830
|
|
[8]
|
Jones, T. (2012) Insight into Snake Venom Evolution Could Aid Drug Discovery. Planet Earth Online, NERC-Science of the Environment, 1.
http://planetearth.nerc.ac.uk/news/story.aspx?id=1291&cookieConsent=A
|
|
[9]
|
AAP (2012) Snake Venom Could Treat Cancer. The West Australian, 21 September.
https://au.news.yahoo.com/thewest/lifestyle/a/14914579/snake-venom-could-treat-cancer
|
|
[10]
|
Hailey, S., Adams, E., Peng, R., Wong, A. and McLane, M.A. (2013) Effect of the Disintegrin Eristostatin on Melanoma-Natural Killer Cell Interactions. Toxicon, 6, 83-93.
http://www.sciencedirect.com/science/article/pii/S0041010112007751
|
|
[11]
|
The Economist (2013) Snake Venom Is Being Used to Cure, Rather than Kill. The Economist, 5 January.
http://www.economist.com/news/science-and-technology/21569015-snake-venom-being-used-cure-rather-kill-toxic-medicine
|
|
[12]
|
Pyrko, P., Wang, W., Markland, F.S., Swenson, S.D., Schmitmeier, S., Schönthal, A.H. and Chen, T.C. (2005) The Role of Contortrostatin, a Snake Venom Disintegrin, in the Inhibition of Tumor Progression and Prolongation of Survival in a Rodent Glioma Model. Journal of Neurosurgery, 103, 526-537.
http://www.ncbi.nlm.nih.gov/pubmed/16235686
|
|
[13]
|
Swenson, S., Costa, F., Ernst, W., Fujii, G. and Markland, F.S. (2005) Contortrostatin, a Snake Venom Disintegrin with Anti-Angiogenic and Anti-Tumor Activity. Pathophysiology of Haemostasis and Thrombosis, 34, 169-176.
http://www.ncbi.nlm.nih.gov/pubmed/16707922
|
|
[14]
|
Selistre-de-Araujo, H.S., Pontes, C.L.S., Montenegro, C.F. and Martin, A.C.B.M. (2010) Snake Venom Disintegrins and Cell Migration. Toxins (Basel), 2, 2606-2621.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3153172/#__ffn_sectitle
|
|
[15]
|
Marcinkiewicz, C. (2005) Functional Characteristic of Snake Venom Disintegrins: Potential Therapeutic Implication. Current Pharmaceutical Design, 11, 815-827.
|
|
[16]
|
Zicha, J., Dobesová, Z. and Kunes, J. (2006) Antihypertensive Mechanisms of Chronic Captopril or N-Acetylcysteine Treatment in L-NAME Hypertensive Rats. Hypertension Research, 29, 1021-1027.
http://www.nature.com/hr/journal/v29/n12/pdf/hr2006140a.pdf
|
|
[17]
|
James Mitchell Crow (2012) Venomous Drugs: Captopril. New Scientist, 214, 35.
http://www.sciencedirect.com/science/article/pii/S0262407912611713
|
|
[18]
|
Bryan, J. (2009) From Snake Venom to ACE Inhibitor—The Discovery and Rise of Captopril. The Pharmaceutical Journal, 282, 455.
http://www.pharmaceutical-journal.com/news-and-analysis/news/from-snake-venom-to-ace-inhibitor-the-discovery-and-rise-of-captopril/10884359.article
|
|
[19]
|
Miguel-Carrasco, J.L., Zambrano, S., Blanca, A.J., Mate, A. and Vázquez, C.M. (2010) Captopril Reduces Cardiac Inflammatory Markers in Spontaneously Hypertensive Rats by Inactivation of NF-kB. Journal of Inflammation, 7, 21.
http://www.journal-inflammation.com/content
|
|
[20]
|
Cossins, D. (2013) From Toxins to Therapeutics. The Scientist, 1.
http://www.the-scientist.com/?articles.view/articleNo/34745/title/From-Toxins-to-Therapeutics
|
|
[21]
|
Shen, H. (2012) Deadly Snake Venom Delivers Pain Relief. Nature, 1.
http://www.nature.com/news/deadly-snake-venom-delivers-pain-relief-1.11526
|
|
[22]
|
Woolf, C.J. (2013) Pain: Morphine, Metabolites, Mambas and Mutations. The Lancet Neurology, 12, 18-20.
http://www.sciencedirect.com/science/article/pii/S1474442212702879
|
|
[23]
|
Keber, P. (2013) Using Snake Venom for Medicine. The Weather Network, 1.
http://www.theweathernetwork.com/news/articles/using-snake-venom-for-medicine/9860/
|
|
[24]
|
Rally, D.T. (2010) Viper Room: Is Snake Venom the Cure for Wrinkles? Elle Canada, 1.
http://www.ellecanada.com/beauty/viper-room-is-snake-venom-the-cure-for-wrinkles/a/36441/2#.VAd8OMWSw2A
|
|
[25]
|
Bonnier Corporation (2008) Evolution’s Most Effective Killer: Snake Venom. Popular Science, 272, 116.
http://www.popsci.com/scitech/article/2008-03/evolution%E2%80%99s-most-effective-killer-snake-venom
|
|
[26]
|
McCleary, R.J. and Kini, R.M. (2013) Non-Enzymatic Proteins from Snake Venoms: A Gold Mine of Pharmacological Tools and Drug Leads. Toxicon, 62, 56-74.
|
|
[27]
|
dos Santos, J.I., Cintra-Francischinelli, M., Borges, R.J., Fernandes, C.A., Pizzo, P., Cintra, A.C., Braz, A.S., Soares, A.M. and Fontes, M.R. (2011) Structural, Functional, and Bioinformatics Studies Reveal a New Snake Venom Homologue Phospholipase A2 Class. Proteins, 79, 61-78.
http://www.ncbi.nlm.nih.gov/pubmed/20878713
|